Search
On November 3, United Therapeutics Corporation, a prominent U.S. biotechnology firm, declared the successful completion of the world's inaugural clinical trial surgery, which involved the transplantation of a gene-edited pig kidney into a human patient at NYU Langone Health in New York City. This milestone event officially heralded the commencement of large-scale clinical trials for this innovative procedure. As per reports from U.S. media outlets, this marks the first large-scale clinical trial authorized by the FDA for the transplantation of gene-edited pig kidneys into humans. The primary objective of this trial is to conduct a systematic assessment of the safety and efficacy of these gene-edited pig kidneys in patients suffering from end-stage renal disease.
-
C114 Communication Network -
Communication Home
